These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34427377)

  • 1. A case of pediatric psoriasis successfully and rapidly treated with ixekizumab.
    Megna M; Fornaro L; De Lucia M; Rescigno O; Camela E; Fabbrocini G
    Dermatol Ther; 2021 Nov; 34(6):e15108. PubMed ID: 34427377
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of severe psoriasis in a 84-year-old women successfully treated with ixekizumab.
    Gallo L; Ruggiero A; Fabbrocini G; Megna M
    Dermatol Ther; 2020 May; 33(3):e13299. PubMed ID: 32157763
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience of ixekizumab in the treatment of patients with history of chronic erythrodermic psoriasis who failed secukinumab: a case series.
    Lo Y; Tsai TF
    Br J Dermatol; 2019 Nov; 181(5):1106-1107. PubMed ID: 31145806
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment with ixekizumab of lower-limb linear psoriasis in a child.
    Pourchot D; Mery-Bossard L; Petitjean B; Mahé E; Thomas-Beaulieu D
    Ann Dermatol Venereol; 2022 Sep; 149(3):216-218. PubMed ID: 35282894
    [No Abstract]   [Full Text] [Related]  

  • 5. Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3.
    Egeberg A; Wu JJ; Korman N; Solomon JA; Goldblum O; Zhao F; Mallbris L
    J Am Acad Dermatol; 2018 Jul; 79(1):104-109.e8. PubMed ID: 29548945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Educational service correlates with greater improvement and adherence in psoriasis patients responding to ixekizumab.
    Hu K; Shen M; Zhang M; Kuang Y
    J Dtsch Dermatol Ges; 2023 Aug; 21(8):900-902. PubMed ID: 37480160
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful response of genital psoriasis to ixekizumab: report of six cases.
    García-Legaz Martínez M; Martínez-Doménech Á; Hernández-Bel P; Magdaleno-Tapial J; Valenzuela-Oñate C; Pérez-Pastor G; Sánchez-Carazo JL; Alegre-de Miquel V; Pérez-Ferriols A
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):e325-e327. PubMed ID: 30980763
    [No Abstract]   [Full Text] [Related]  

  • 8. Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy.
    Giunta A; Ventura A; Chimenti MS; Bianchi L; Esposito M
    Drug Des Devel Ther; 2017; 11():1643-1651. PubMed ID: 28652702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ixekizumab as treatment of erythrodermic psoriasis.
    Trovato E; Orsini C; Russo F; Cortonesi G; Rubegni P
    Dermatol Ther; 2021 Mar; 34(2):e14868. PubMed ID: 33571383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful switching to brodalumab in a patient with severe psoriasis developing ixekizumab-induced eczema.
    Kimura R; Sugita K; Yamamoto O
    Eur J Dermatol; 2020 Dec; 30(6):732-734. PubMed ID: 33237034
    [No Abstract]   [Full Text] [Related]  

  • 11. Ixekizumab for the treatment of pediatric patients with moderate to severe plaque psoriasis.
    Cather JC; Young CT; Young MS; Cather JC
    Expert Opin Biol Ther; 2021 Aug; 21(8):983-990. PubMed ID: 34106794
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies.
    Griffiths CEM; Fava M; Miller AH; Russell J; Ball SG; Xu W; Acharya N; Rapaport MH
    Psychother Psychosom; 2017; 86(5):260-267. PubMed ID: 28903122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis.
    Yosipovitch G; Dong Y; Burge R; Zhu B; Shrom D; Kimball AB
    Acta Derm Venereol; 2019 Oct; 99(11):1031-1032. PubMed ID: 31290556
    [No Abstract]   [Full Text] [Related]  

  • 14. Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failed.
    Kimmel G; Chima M; Kim HJ; Bares J; Yao CJ; Singer G; Kim SJ; Bagel J; Lebwohl M
    J Am Acad Dermatol; 2019 Sep; 81(3):857-859. PubMed ID: 31078609
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of erythrodermic psoriasis successfully treated with ixekizumab.
    Megna M; Gallo L; Balato N; Balato A
    Dermatol Ther; 2019 Mar; 32(2):e12825. PubMed ID: 30650216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ixekizumab on nail psoriasis in paediatric patients with moderate-to-severe psoriasis: a post hoc analysis from IXORA-PEDS.
    Seyger MMB; Reich A; El Baou C; Schuster C; Riedl E; Paller AS
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e911-e913. PubMed ID: 34320259
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3).
    Reich K; Leonardi C; Lebwohl M; Kerdel F; Okubo Y; Romiti R; Goldblum O; Dennehy EB; Kerr L; Sofen H
    J Dermatolog Treat; 2017 Jun; 28(4):282-287. PubMed ID: 27759463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ixekizumab in nail psoriasis.
    Dattola A; Manfreda V; Mazzilli S; Bianchi L; Giunta A
    Dermatol Ther; 2020 May; 33(3):e13352. PubMed ID: 32232895
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitiligo development in a patient with psoriasis vulgaris treated with ixekizumab.
    Eker H; Kaya İslamoğlu ZG; Demirbaş A
    Dermatol Ther; 2022 Apr; 35(4):e15314. PubMed ID: 35019197
    [No Abstract]   [Full Text] [Related]  

  • 20. Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective study.
    Deza G; Notario J; Lopez-Ferrer A; Vilarrasa E; Ferran M; Del Alcazar E; Carrascosa JM; Corral M; Salleras M; Ribera M; Puig L; Pujol RM; Vidal D; Gallardo F
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):553-559. PubMed ID: 30317679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.